Cover Image

Costs of pharmacological and non-pharmacological interventions in interstitial lung disease management in Germany

Interstitial lung diseases (ILDs) are associated with a high economic burden, yet prospective data of the German healthcare system are sparse. We assessed average ILD-related costs of pharmacological and non-pharmacological (hospitalizations, outpatient, rehabilitation, physiotherapy, and medical ai...

Full description

Saved in:
Bibliographic Details
Main Authors: Maqhuzu, Phillen Nozibuyiso (Author) , Schwarzkopf, Larissa (Author) , Markart, Philipp (Author) , Behr, Juergen (Author) , Holle, Rolf (Author) , Leidl, Reiner (Author) , Kreuter, Michael (Author)
Format: Article (Journal)
Language:English
Published: October 27, 2022
In: Respiration
Year: 2022, Volume: 101, Issue: 11, Pages: 1015-1023
ISSN:1423-0356
DOI:10.1159/000526575
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000526575
Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/526575
Get full text
Author Notes:Phillen Nozibuyiso Maqhuzu, Larissa Schwarzkopf, Philipp Markart, Juergen Behr, Rolf Holle, Reiner Leidl, Michael Kreuter
Description
Summary:Interstitial lung diseases (ILDs) are associated with a high economic burden, yet prospective data of the German healthcare system are sparse. We assessed average ILD-related costs of pharmacological and non-pharmacological (hospitalizations, outpatient, rehabilitation, physiotherapy, and medical aids) interventions in ILD.
Item Description:Gesehen am 09.11.2023
Physical Description:Online Resource
ISSN:1423-0356
DOI:10.1159/000526575

Similar Items